e-Article
Weekly cabazitaxel plus prednisone is effective and less toxic for ‘unfit’ metastatic castration-resistant prostate cancer: Phase II Spanish Oncology Genitourinary Group (SOGUG) trial
Document Type
Article
Author
Climent, Miguel Ángel; Pérez-Valderrama, Begoña; Mellado, Begoña; Fernández Parra, Eva María; Fernández Calvo, Ovidio; Ochoa de Olza, María; Muinelo Romay, Laura; Anido, Urbano; Domenech, Montserrat; Hernando Polo, Susana; Arranz Arija, José Ángel; Caballero, Cristina; Juan Fita, María José; Castellano, Daniel
Source
In European Journal of Cancer December 2017 87:30-37
Subject
Language
ISSN
0959-8049